PNRR_Postdoctoral Scientist- Innate immunity in inflammation and cancer

Località: 

Rozzano, IT, 20089

                                                                                         

Job title: Postdoctoral Scientist- Innate immunity in inflammation and cancer

As part of the National Plan for Recovery and Resilience (Piano Nazionale di Ripresa e Resilienza, PNRR), IRCCS Istituto Clinico Humanitas has started the public selection procedures for recruitment under the projects regarding the Enhancement and strengthening of biomedical research in the NHS.

TITLE AND BRIEF PROJECT DESCRIPTION: Uncovering novel targets and pathways to enhance the efficacy of combination immunotherapy for lung cancer KMN309-CUP: E23C24000220006

 

Immunotherapies with immune checkpoint inhibitors (ICIs) have revolutionized the treatment of solid tumors, including lung cancer. Combining ICIs with conventional chemotherapy has proven successful, but only in a subset of patients. Although ICIs reinvigorate dysfunctional T cells against the cancer, acquired resistance occurs due to additional suppressive mechanisms, such as alternative checkpoints, inhibitory cell populations, and insufficient inflammation, among others. However, knowledge in this area is limited. Using a multitask approach that combines state-of-the-art technologies with the advantages of genetically engineered mice, models of primary carcinogenesis, and investigations in human samples, we will unravel the complex relationships between the immune system, the stroma, and the tumor. Our aim is to discover major cellular and molecular mechanisms of resistance, which will be further explored in preclinical models of lung cancer to enhance tumor regression.

 

Job profile and brief description of activities required:

 

Postdoctoral Scientist to join the Innate immunity in inflammation and cancer Lab led by Dr. Sebastien Jaillon.  For more information, visit Sebastien Jaillon Group.

 

The successful candidate will be responsible of:

  • Pursuing the program of work agreed with the Group Leader.
  • Designing and executing experiments.
  • Establishing procedures and developing new approaches; acquiring new skills.
  • Maintaining accurate records of experiments and reagents.
  • Preparing and presenting work at and attending weekly laboratory meetings.

 

Qualifications required

  • PhD in immunology, cancer biology or related fields.
  • Solid background in immunology, with a strong understanding of tumor immunology, and familiarity with cellular and molecular biology, and standard mouse work.
  • Experience in immune profiling of cancer samples.
  • Experience in mouse handling.

Preferred candidate choice requirements

  • Familiarity with mouse cancer models, RNA sequencing, flow cytometry, tissue culture, and data analysis.
  • Highly motivated, detail-oriented, organized, flexible, and a team player.
  • Excellent written and spoken English.
  • Ability to collaborate effectively with colleagues.
  • Learn and apply new skills.
  • Capacity to engage in constructive debate and support lab objectives.
  • Commitment to maintaining a safe and compliant working environment.

 

Informal inquiries are welcomed and should be directed to: sebastien.jaillon@humanitasresearch.it

 

Humanitas sulla base dei profili ricevuti, attiverà nei termini indicati dal presente avviso, il processo di selezione invitando i candidati idonei a partecipare ai colloqui di selezione, previa verifica del cv e dei titoli, che si terranno in presenza o in modalità telematica.

La commissione di selezione, composta dal Responsabile del Progetto e dalla Direzione Risorse Umane, si farà carico della valutazione complessiva delle candidature ricevute e ne darà un feedback ai candidati entro 60 giorni dal primo colloquio.

 

L’avviso è rivolto a candidatə nel rispetto del Dlgs 198/2006 e dei Dlgs 215/2003 e 216/2003.

Le persone interessate sono invitate a leggere l'informativa privacy ex artt. 13 e 14 del Reg. UE 2016/679.

 

 

Data pubblicazione avviso: 04 / 09 / 2025

Data Scadenza avviso: 30 / 09 / 2025

Data di inserimento prevista: 10 / 10 / 2025